CHRO: Chromocell Therapeutics Corporation Sotuvga nisbatan narx
Global mojarolar va biomateriallar logistikasining buzilishi yangi dori vositalarining xalqaro sinovlariga to'sqinlik qilmoqda. Sotuvlarga nisbatan narx koeffitsiyenti tendentsiyasi ushbu omillarning ta'sirini tasdiqlaydi, bunda bazaviy parametr qiymati vazifasini bajaradi. Biroq, biomeditsinaning gumanitar maqomi sanksiyalar xavfini minimallashtiradi. Chromocell Therapeutics (CHRO) kompaniyasining yakuniy muvaffaqiyati opioid bo'lmagan analgetiklar xavfsizligiga bog'liq bo'lib, ular kompaniyaning bozor potentsialini belgilaydi.
Chromocell Therapeutics Corporation (CHRO) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- bozor narxi va tahlilchilarning maqsadli narxlari:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati Chromocell Therapeutics|CHRO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli kreditlarning kapitalga nisbati Chromocell|CHRO - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati Chromocell Therapeutics Corporation|CHRO - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Chromocell Therapeutics|Oraliq qoplash koeffitsiyenti chromocell.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
CHRO - Sof foyda|Prognoz qilingan kelajakdagi foyda Chromocell Therapeutics|CHRO - Narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati Chromocell Therapeutics Corp|CHRO - PEG multiplikatori|Kompaniya qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Chromocell Therapeutics Corporation|CHRO - Eskirish chegirilmasdan oldingi operatsion foyda|Bir aksiya uchun sof foyda (EPS TTM) Chromocell Therapeutics|CHRO - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati chromocell.com|CHRO - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Chromocell Therapeutics
- umumiy tushum va sotuv hajmi ma'lumotlari:
Kompaniyaning umumiy tahlili:chromocell.com, CHRO
P/S koeffitsiyenti biznesning bozor qiymatini uning yillik daromadiga nisbatan belgilaydi, bu esa investorga sotuvlarning har bir dollari uchun to'langan premiumni baholash imkonini beradi. Tarixiy P/S tendentsiyalarini tahlil qilish orqali Chromocell Therapeutics (CHRO) kompaniyasining bozor kapitalizatsiyasini uning opioid bo'lmagan og'riq qoldiruvchi dori vositalarini ishlab chiqish (R&D) samaradorligi bilan solishtirish mumkin, bunda ushbu ko'rsatkichdagi har qanday og'ishlar FDA tomonidan molekula tasdiqlanishi istiqbollarining bozor tomonidan qayta baholanishidan dalolat beradi.
Raqobatdosh kompaniyalar
Kapitalizatsiyaning daromadga nisbati biogen.com BIIB|P/S multiplikatori NBIX (Neurocrine Biosciences, Inc.)|Regencell Bioscience Ltd (RGC) - Sotuvga nisbatan narx|AXSM - Narxning daromadga nisbati|ACAD: Narxning daromadga nisbati|Xenon Pharmaceuticals (XENE) - Narxning daromadga nisbati|VKTX (vikingtherapeutics.com) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati SUPN|CPRX: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati DNLI (Denali Therapeutics Inc)|Kapitalizatsiyaning sotish hajmiga nisbati HRMY|P/S multiplikatori BHVN (Biohaven Ltd.)|Bozor kapitallashuvining daromadga nisbati AMLX|Trevi Therapeutics, Inc. - P/S multiplikatori|Sotuvga nisbatan narx Praxis Precision Medicines Inc|Anavex Corp (AVXL) - Narxning daromadga nisbati|CeriBell EEG - Bozor kapitallashuvining daromadga nisbati|PRTA (Prothena Biosciences) - P/S multiplikatori|P/S multiplikatori Alector Therapeutics|Narxning daromadga nisbati Annexon (ANNX)|OMER: Narxning sotuvga nisbati|P/S multiplikatori NGNE (Neurogene Corp)|AC Immune Inc (ACIU) - Sotuvga nisbatan narx|VYGR: Kapitalizatsiyaning daromadga nisbati|NMRA - P/S multiplikatori|SCLX (Scilex) - Kapitalizatsiyaning daromadga nisbati|TVGN: Kapitalizatsiyaning sotish hajmiga nisbati|ACOG (Alpha Cognition Inc) - P/S multiplikatori|Cognition Therapeutics Inc. (CGTX) - Narx/daromad koeffitsiyenti|P/S multiplikatori IKT|Kapitalizatsiyaning daromadga nisbati cassavasciences.com SAVA|Narxning daromadga nisbati Assertio ASRT|Narx/daromad koeffitsiyenti Coya Therapeutics Inc (COYA)|VistaGen Therapeutics Inc - P/S multiplikatori|Ovid Therapeutics Inc. (OVID) - Kapitalizatsiyaning daromadga nisbati|ABOS: P/S multiplikatori|cervomed.com - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Alterity Therapeutics Ltd.|CLNN: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati PepGen Inc. (PEPG)|JUNS - Sotuvga nisbatan narx|Narxning daromadga nisbati Relmada Therapeutics RLMD|ANVS: Kapitalizatsiya va daromad nisbati|Grace Tx - P/S multiplikatori|Sotuvga nisbatan narx Firefly Neuroscience, Inc.|KLTO (anewmeds.com) - Kapitalizatsiyaning daromadga nisbati|NeuroSense Therapeutics Ltd. (NRSN) - P/S multiplikatori|Narxning daromadga nisbati Reviva Pharmaceuticals|MTVA: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati NeurAxis (NRXS)|HSDT - Sotuvga nisbatan narx|P/S multiplikatori PASG (Passage Bio)|NEUP - Kapitalizatsiyaning daromadga nisbati|Minerva Neurosciences - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ATHA (athira.com)|Addex Therapeutics Ltd (ADXN) - Narxning daromadga nisbati|Alzamend Neuro - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Cyclerion Therapeutics Inc.|Sotuvga nisbatan narx Protagenic PTIX|Narxning daromadga nisbati Pasithea Therapeutics (KTTA)|Kapitalizatsiyaning daromadga nisbati cortigent.com CRGT|Narxning daromadga nisbati Avenue Therapeutics, Inc. ATXI|Brainstorm Cell Therapeutics Inc. (BCLI) - Sotuvga nisbatan narx|Cara Therapeutics, Inc - P/S multiplikatori|Eliem Therapeutics (ELYM) - Kapitalizatsiyaning daromadga nisbati|ITCI: P/S multiplikatori|Sotuvga nisbatan narx longboardpharma.com (LBPH)|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|Narxning daromadga nisbati NKGN|Narxning daromadga nisbati NeuroBo (NRBO)|Narxning daromadga nisbati SAGE (Sage Therapeutics Inc)|Synaptogenix, Inc. - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati TRVN|VIGL: Kapitalizatsiyaning daromadga nisbati|anewmeds.com - Kapitalizatsiyaning sotish hajmiga nisbati|CERE: P/S multiplikatori
